Nukkleus (NASDAQ:DFNS) Posts Earnings Results

Nukkleus (NASDAQ:DFNS) issued its quarterly earnings results on Tuesday. The company reported ($180.72) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($3.11) by ($177.61), Zacks reports.

Nukkleus Stock Performance

Shares of DFNS traded down $3.79 during trading hours on Tuesday, hitting $27.20. The company’s stock had a trading volume of 180,484 shares, compared to its average volume of 1,308,174. The company has a debt-to-equity ratio of 0.07, a current ratio of 0.25 and a quick ratio of 0.21. The company has a market cap of $20.67 million, a price-to-earnings ratio of -0.07 and a beta of -5.80. Nukkleus has a 52-week low of $3.70 and a 52-week high of $1,948.75. The business has a 50 day simple moving average of $25.61 and a two-hundred day simple moving average of $96.91.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets purchased a new position in shares of Nukkleus during the 2nd quarter valued at about $56,000. UBS Group AG grew its position in Nukkleus by 23.3% during the third quarter. UBS Group AG now owns 80,512 shares of the company’s stock valued at $564,000 after acquiring an additional 15,223 shares during the last quarter. Ausdal Financial Partners Inc. purchased a new position in shares of Nukkleus during the third quarter worth approximately $105,000. Geode Capital Management LLC raised its stake in shares of Nukkleus by 193.7% during the fourth quarter. Geode Capital Management LLC now owns 124,714 shares of the company’s stock worth $503,000 after acquiring an additional 82,252 shares in the last quarter. Finally, LPL Financial LLC bought a new stake in shares of Nukkleus in the 4th quarter worth approximately $120,000. 12.47% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on DFNS shares. Wall Street Zen cut Nukkleus from a “sell” rating to a “strong sell” rating in a report on Saturday. Noble Financial raised shares of Nukkleus to a “strong-buy” rating in a research report on Monday, June 29th. Finally, Weiss Ratings downgraded Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research note on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.

Nukkleus Company Profile

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.